ReShape Lifesciences,

Share on: 
Description: 

ReShape Lifesciences, Inc. is a developer of minimally invasive medical devices to treat obesity and metabolic diseases.
St. Paul, Minnesota October 23, 2017 – EnteroMedics Inc. (NASDAQ:ETRM), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that the Company has formally changed its name to ReShape Lifesciences Inc. (NASDAQ: RSLS).

Career Page(s): 
Location(s): 
San Clemente CA
United States